pyrvinium has been researched along with Germinoblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayakawa, F; Katakai, T; Kiyoi, H; Morishita, T; Naoe, T; Shimada, K; Shimada, S; Sugimoto, K; Tomita, A | 1 |
| Rajoria, P; Wang, C; Xiao, M; Zhang, L; Zhou, Y | 1 |
2 other study(ies) available for pyrvinium and Germinoblastoma
| Article | Year |
|---|---|
Discovery of a drug targeting microenvironmental support for lymphoma cells by screening using patient-derived xenograft cells.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; Coculture Techniques; Drug Discovery; Glutathione; Humans; Interleukin Receptor Common gamma Subunit; Lymphoma; Mice; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Oxidative Stress; Pyrvinium Compounds; Reactive Oxygen Species; Transplantation, Heterologous; Tumor Cells, Cultured; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2015 |
Pyrvinium selectively induces apoptosis of lymphoma cells through impairing mitochondrial functions and JAK2/STAT5.
Topics: Anthelmintics; Antineoplastic Agents; Apoptosis; Cell Respiration; Dose-Response Relationship, Drug; Humans; Janus Kinase 2; Jurkat Cells; Lymphoma; Mitochondria; Pyrvinium Compounds; Signal Transduction; STAT5 Transcription Factor | 2016 |